Table 1.
Summary of FEZ1 gene expression in various cancers
| Origin of cancer samples | No. of cases analyzed | Cases expressing FEZ1 mRNAs | No. of cases with aberrant size transcripts (case names) |
|---|---|---|---|
| Esophagus | |||
| Cell lines | 4 | 1 | 1 (TE8) |
| Primary tumors | 12 | 9* | 4 (E16, E26, E41, E62) |
| Gastric cell lines | 8 | 3* | Not done |
| Colon cell lines | 3 | 2 | 1 (SW480) |
| Prostate | |||
| Cell lines | 3 | 2 | 1 (DU145) |
| Primary tumors | 3 | 0* | |
| Breast | |||
| Cell lines | 15 | 0 | |
| Primary tumors | 10 | 0* | |
| Hematopoietic cell lines | 5 | 1 | 1 (MOLT4) |
| Lung cell lines | 1 | 0 | |
| Melanoma cell lines | 1 | 1 | 1 (G361) |
| Cervical cell lines | 1 | 0 |
The FEZ1 expression was analyzed by Northern blot or RT-PCR.
*
, Analyzed by RT-PCR.